Journal article · 2023 · Open access

Development of HIV-Resistant CAR T Cells by CRISPR/Cas-Mediated CAR Integration into the CCR5 Locus

Frederik Holm Rothemejer, Nanna Pi Lauritsen, Anna Karina Juhl, Mariane Høgsbjerg Schleimann, Saskia König, Ole Schmeltz Søgaard, Rasmus Otkjær Bak, Martin Tolstrup

Viruses, 15(1), 202 · Published 10 January 2023 · DOI 10.3390/v15010202

Open PDFView at the publisherCite this paper

In brief

“Development of HIV-Resistant CAR T Cells by CRISPR/Cas-Mediated CAR Integration into the CCR5 Locus” is a 2023 journal article by Frederik Holm Rothemejer and 7 co-authors, published in Viruses. OpenAlex counts 36 citations as of 19 November 2026, which puts it in the top 4% of works published in 2023 by citations. It is open access under a CC BY licence: the full text is free to read at Viruses.

Citations
36
Most cited in
2026 (14)
Field-weighted impact
4.00
References
46
Authors
8

Abstract

Adoptive immunotherapy using chimeric antigen receptor (CAR) T cells has been highly successful in treating B cell malignancies and holds great potential as a curative strategy for HIV infection. Recent advances in the use of anti-HIV broadly neutralizing antibodies (bNAbs) have provided vital information for optimal antigen targeting of CAR T cells. However, CD4+ CAR T cells are susceptible to HIV infection, limiting their therapeutic potential. In the current study, we engineered HIV-resistant CAR T cells using CRISPR/Cas9-mediated integration of a CAR cassette into the CCR5 locus. We used a single chain variable fragment (scFv) of the clinically potent bNAb 10-1074 as the antigen-targeting domain in our anti-HIV CAR T cells. Our anti-HIV CAR T cells showed specific lysis of HIV-infected cells in vitro. In a PBMC humanized mouse model of HIV infection, the anti-HIV CAR T cells expanded and transiently limited HIV infection. In conclusion, this study provides proof-of-concept for developing HIV-resistant CAR T cells using CRISPR/Cas9 targeted integration.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Rothemejer, F. H., Lauritsen, N. P., Juhl, A. K., Schleimann, M. H., König, S., Søgaard, O. S., Bak, R. O., & Tolstrup, M. (2023). Development of HIV-Resistant CAR T Cells by CRISPR/Cas-Mediated CAR Integration into the CCR5 Locus. Viruses, 15(1), 202. https://doi.org/10.3390/v15010202

MLA 9

Rothemejer, Frederik Holm, et al. “Development of HIV-Resistant CAR T Cells by CRISPR/Cas-Mediated CAR Integration into the CCR5 Locus.” Viruses, vol. 15, no. 1, 2023, p. 202. https://doi.org/10.3390/v15010202.

Chicago

Rothemejer, Frederik Holm, Nanna Pi Lauritsen, Anna Karina Juhl, Mariane Høgsbjerg Schleimann, Saskia König, Ole Schmeltz Søgaard, Rasmus Otkjær Bak, and Martin Tolstrup. 2023. “Development of HIV-Resistant CAR T Cells by CRISPR/Cas-Mediated CAR Integration into the CCR5 Locus.” Viruses 15 (1): 202. https://doi.org/10.3390/v15010202.

Harvard

Rothemejer, F. H. et al. (2023) ‘Development of HIV-Resistant CAR T Cells by CRISPR/Cas-Mediated CAR Integration into the CCR5 Locus’, Viruses, 15(1), p. 202. doi:10.3390/v15010202.

IEEE

F. H. Rothemejer et al., “Development of HIV-Resistant CAR T Cells by CRISPR/Cas-Mediated CAR Integration into the CCR5 Locus,” Viruses, vol. 15, no. 1, p. 202, 2023, doi: 10.3390/v15010202.

BibTeX

@article{rothemejer2023development,
  title     = {{Development of HIV-Resistant CAR T Cells by CRISPR/Cas-Mediated CAR Integration into the CCR5 Locus}},
  author    = {Rothemejer, Frederik Holm and Lauritsen, Nanna Pi and Juhl, Anna Karina and Schleimann, Mariane Høgsbjerg and König, Saskia and Søgaard, Ole Schmeltz and Bak, Rasmus Otkjær and Tolstrup, Martin},
  journal   = {Viruses},
  year      = {2023},
  volume    = {15},
  number    = {1},
  pages     = {202},
  doi       = {10.3390/v15010202},
  url       = {https://doi.org/10.3390/v15010202}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202344
202488
20251010
20261414

Its field-weighted citation impact is 4.00: it has been cited 4.00 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › CAR-T cell therapy research

  • chimeric antigen receptor T cells
  • CRISPR/Cas9 genome editing
  • HIV infection
  • broadly neutralizing antibodies
  • CD4+ T cells
  • humanized mice
  • adoptive immunotherapy

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Rothemejer, F. H., Lauritsen, N. P., Juhl, A. K., Schleimann, M. H., König, S., Søgaard, O. S., Bak, R. O., & Tolstrup, M. (2023). Development of HIV-Resistant CAR T Cells by CRISPR/Cas-Mediated CAR Integration into the CCR5 Locus. Viruses, 15(1), 202. https://doi.org/10.3390/v15010202

How many times has this paper been cited?

36 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Viruses: sign in and open the PDF from this page.

Who wrote this paper?

Frederik Holm Rothemejer, Nanna Pi Lauritsen, Anna Karina Juhl, Mariane Høgsbjerg Schleimann, Saskia König, Ole Schmeltz Søgaard, Rasmus Otkjær Bak, Martin Tolstrup.

What is the DOI of this paper?

10.3390/v15010202, permanently at https://doi.org/10.3390/v15010202. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.